Showing results (1451-1460 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|May 1, 1993
Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck. A Southwest Oncology Group trialS A Taylor, J Benedetti, D Schuller, et al.Investigational New Drugs|May 1, 1993
Phase II trial of carbetimer in metastatic melanomaW D Quan, M S MitchellInvestigational New Drugs|February 25, 2010
B1, a novel naphthalimide-based DNA intercalator, induces cell cycle arrest and apoptosis in HeLa cells via p53 activationXin Liang, Aibin Wu, Yufang Xu, et al.Investigational New Drugs|February 26, 2010
Influence of pharmacogenetic variability on the pharmacokinetics and toxicity of the aurora kinase inhibitor danusertibNeeltje Steeghs, Ron H J Mathijssen, Judith A M Wessels, et al.Investigational New Drugs|February 1, 1991
Preclinical antitumor activity of CI-973,[SP-4-3-(R)]-[1,1- cyclobutanedicarboxylato(2-)](2 methyl-1,4-butane-diamine-N,N')platinumA J Kraker, C W Moore, B J Roberts, et al.Investigational New Drugs|February 1, 1991
Phase II clinical trial of 4'-O-tetrahydropyranyl-adriamycin (THP-adriamycin) in recurrent squamous cell carcinoma of the head and neckD M Shin, A M Kramer, I W Dimery, et al.Investigational New Drugs|March 6, 2010
Baicalin induces human mucoepidermoid carcinoma Mc3 cells apoptosis in vitro and in vivoXiao-Fang Xu, Bo-Lei Cai, Su-Min Guan, et al.Investigational New Drugs|January 1, 1984
Methyl-glyoxal bis guanyl hydrazone (methyl-GAG, MGBG) in advanced breast cancer. A Phase II trial of the Southwest Oncology GroupW A Knight, R M O'Bryan, B Samal, et al.Investigational New Drugs|January 1, 1984
Phase II trial of bisantrene in patients with intermediate and high grade diffuse non-Hodgkin's lymphomasT P Miller, S E Jones, D S Alberts, et al.Investigational New Drugs|January 1, 1984
The key role of hydroxylation for the cytostatic activity and selectivity of cyclophosphamideP Hilgard, N BrockPageof 372